Using bright X-rays from the Department of Energy's SLAC National Accelerator Laboratory and Lawrence Berkeley National ...
Headlining this week’s starting Green Deals is a spotlight on the ENGWE EP-2 3.0 Fast Charging Long-Range Foldable Commuter ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for patients with ...
Q VYJUVEK global revenue and $846.7 million since launchEnrollment complete in KB803 (corneal abrasions in DEB patients) ...
These drugs fall into a class known as GLP-1s, mimicking a natural hormone that helps regulate blood sugar, slows how quickly ...
bAirway Research Center North, German Center for Lung Research, LungenClinic Grosshansdorf and Christian Albrechts University of Kiel, Kiel, Germany cSection on Pulmonary and Critical Care Medicine, ...
As more products reach the market, therapy developers partner with researchers and regulators to deliver N-of-1 treatments to patients.
Halide perovskites are gaining ground on silicon as a critical material for solar cell technologies: A new study published in ...
Aicuris’s pritelivir is forecast to be a significant advancement for immunocompromised patients with refractory HSV infections.
A 13-year-old boy with no history presented after 4 days of progressively worsening whole body rash.Nine days before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results